Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
Carlo-Stella C
Bone Marrow Transplant. 20(6):465-71.
Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C
Haematologica. 82(3):291-6.
Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation.
Almici C
Bone Marrow Transplant. 19(11):1079-84.
In vitro growth of mobilized peripheral blood progenitor cells is significantly enhanced by stem cell factor.
Cesana C
Stem Cells. 15(3):207-13.
Arachidonic acid mediates interleukin-1 and tumor necrosis factor-alpha-induced activation of the c-jun amino-terminal kinases in stromal cells.
Rizzo MT, Carlo-Stella C
Blood. 88(10):3792-800.
Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein.
Carlo-Stella C
Blood. 88(8):3091-100.
Detection of maternal progenitor cells in human umbilical cord blood by single-colony karyotyping.
Almici C
Blood. 88(4):1520-1.
Density separation and cryopreservation of umbilical cord blood cells: evaluation of recovery in short-and long-term cultures.
Almici C
Acta Haematol. 95(3-4):171-5.
Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells.
Carlo-Stella C
Br J Haematol. 93(3):551-7.
BCL2 oncogene protein expression in human hematopoietic precursors during fetal life.
Bonati A
Exp Hematol. 24(3):459-65.